Expression of hormone receptors in oropharyngeal squamous cell carcinoma
Hormone receptors play an important role in many types of cancers. Alongside factors associated with human papillomavirus (HPV) infection, hormonal receptors may impact the tumorigenesis of oropharyngeal cancer.
Materials and methods
This study consists of 199 consecutive oropharyngeal squamous cell carcinoma (OPSCC) patients diagnosed and treated with a curative intent. We examined androgen (AR), estrogen (ER; both alpha and beta), and progesterone receptor (PR) expressions using immunohistochemistry comparing tumor and patient characteristics.
AR was expressed in 16%, PR in 27% and ER-beta in 63% of the tumors. HPV- and p16-positive tumors expressed more AR and less PR than their negative counterparts. High PR expression was associated with poor disease-specific and locoregional recurrence-free survival.
AR, PR, and ER-beta are expressed in OPSCC, and AR and PR expressions are associated with HPV and p16 status. Furthermore, PR appears to have prognostic significance. This may allow us to investigate the role of anti-hormone receptors in the treatment of OPSCC.
KeywordsOropharynx Human papillomavirus (HPV) Androgen receptor Estrogen receptor Progesterone receptor
This work was supported by the Helsinki University Hospital Research Funds, the Sigrid Jusélius Foundation, the Otorhinolaryngology Research Foundation, Finnish Dental Association, Apollonia, and Libyan Ministry of Higher Education and Scientific Research.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
The project is part of a larger research project regarding oropharyngeal cancer at the Dept. of Otorhinolaryngology Head and Neck Surgery (HUCH), and an institutional review board approval was obtained from the Research Ethics Committee of the Helsinki University Hospital (HUS). In addition, a hospital study permission was granted (Dnro179/13/03/02/2013). All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
- 1.Ang KK, Harris J, Wheeler R, Weber R, Rosenthal DI, Nguyen-Tan PF, Westra WH, Chung CH, Jordan RC, Lu C, Kim H, Axelrod R, Silverman CC, Redmond KP, Gillison ML (2010) Human papillomavirus and survival of patients with oropharyngeal cancer. N Engl J Med 363(1):24–35. https://doi.org/10.1056/NEJMoa0912217 CrossRefPubMedPubMedCentralGoogle Scholar
- 2.Fakhry C, Zhang Q, Nguyen-Tan PF, Rosenthal D, El-Naggar A, Garden AS, Soulieres D, Trotti A, Avizonis V, Ridge JA, Harris J, Le QT, Gillison M (2014) Human papillomavirus and overall survival after progression of oropharyngeal squamous cell carcinoma. J Clin Oncol 32(30):3365–3373. https://doi.org/10.1200/JCO.2014.55.1937 CrossRefPubMedPubMedCentralGoogle Scholar
- 3.Guo T, Qualliotine JR, Ha PK, Califano JA, Kim Y, Saunders JR, Blanco RG, D’Souza G, Zhang Z, Chung CH, Kiess A, Gourin CG, Koch W, Richmon JD, Agrawal N, Eisele DW, Fakhry C (2015) Surgical salvage improves overall survival for patients with HPV-positive and HPV-negative recurrent locoregional and distant metastatic oropharyngeal cancer. Cancer 121(12):1977–1984. https://doi.org/10.1002/cncr.29323 CrossRefPubMedPubMedCentralGoogle Scholar
- 4.El-Naggar AK, Chan JKC, Grandis JR, Takata T, Slootweg PJ (2017) WHO classification of head and neck tumours, vol 9, 4th edn. Lyon, pp 134–138Google Scholar
- 6.Nasman A, Attner P, Hammarstedt L, Du J, Eriksson M, Giraud G, Ahrlund-Richter S, Marklund L, Romanitan M, Lindquist D, Ramqvist T, Lindholm J, Sparen P, Ye W, Dahlstrand H, Munck-Wikland E, Dalianis T (2009) Incidence of human papillomavirus (HPV) positive tonsillar carcinoma in Stockholm, Sweden: an epidemic of viral-induced carcinoma? Int J Cancer 125(2):362–366. https://doi.org/10.1002/ijc.24339 CrossRefPubMedGoogle Scholar
- 7.Laco J, Vosmikova H, Novakova V, Celakovsky P, Dolezalova H, Tucek L, Nekvindova J, Vosmik M, Cermakova E, Ryska A (2011) The role of high-risk human papillomavirus infection in oral and oropharyngeal squamous cell carcinoma in non-smoking and non-drinking patients: a clinicopathological and molecular study of 46 cases. Virchows Arch 458(2):179–187CrossRefPubMedGoogle Scholar
- 14.Gonzalez LO, Corte MD, Vazquez J, Junquera S, Sanchez R, Alvarez AC, Rodriguez JC, Lamelas ML, Vizoso FJ (2008) Androgen receptor expresion in breast cancer: relationship with clinicopathological characteristics of the tumors, prognosis, and expression of metalloproteases and their inhibitors. BMC Cancer 8:149. https://doi.org/10.1186/1471-2407-8-149 CrossRefPubMedPubMedCentralGoogle Scholar
- 15.Luk PP, Weston JD, Yu B, Selinger CI, Ekmejian R, Eviston TJ, Lum T, Gao K, Boyer M, O'Toole SA, Clark FR, Gupta R (2016) Salivary duct carcinoma: clinicopathologic features, morphologic spectrum, and somatic mutations. Head Neck 38(Suppl 1):E1838–E1847. https://doi.org/10.1002/hed.24332
- 16.Williams L, Thompson LD, Seethala RR, Weinreb I, Assaad AM, Tuluc M, Din NU, Purgina B, Lai C, Griffith CC (2015) Salivary duct carcinoma: the predominance of apocrine morphology, prevalence of histologic variants, and androgen receptor expression. Am J Surg Pathol 39(5):705–713CrossRefPubMedGoogle Scholar
- 24.James D. Brierley MKG, Christian W (2016) TNM classification of malignant tumours, 8th edn. John Wiley, New YorkGoogle Scholar
- 26.Makinen LK, Hayry V, Atula T, Haglund C, Keski-Santti H, Leivo I, Makitie A, Passador-Santos F, Bockelman C, Salo T, Sorsa T, Hagstrom J (2012) Prognostic significance of matrix metalloproteinase-2, -8, -9, and – 13 in oral tongue cancer. J Oral Pathol Med 41(5):394–399. https://doi.org/10.1111/j.1600-0714.2011.01110.x CrossRefPubMedGoogle Scholar
- 27.Bekkers R, van der Avoort I, Melchers W, Bulten J, de Wilde P, Massuger L (2004) Down regulation of estrogen receptor expression is an early event in human papillomavirus infected cervical dysplasia. Eur J Gynaecol Oncol 26(4):376–382Google Scholar
- 29.Burke SC, Smith KV, Sharmin S, Winkelman C (2014) Prevalence of risk factors related to head and neck squamous cell carcinoma (HNSCC) among college students. Cancer Oncol Res 2(1):7–16Google Scholar
- 31.Goulioumis AK, Varakis J, Goumas P, Papadaki H (2011) Androgen receptor in laryngeal carcinoma: could there be an androgen-refractory tumor? ISRN Oncol 2011:180518. https://doi.org/10.5402/2011/180518
- 34.López-Romero R, Garrido-Guerrero E, Rangel-López A, Manuel-Apolinar L, Piña-Sánchez P, Lazos-Ochoa M, Mantilla-Morales A, Bandala C, Salcedo M (2013) The cervical malignant cells display a down regulation of ER-α but retain the ER-β expression. Int J Clin Exp Pathol 6(8):1594–1602PubMedPubMedCentralGoogle Scholar
- 37.Grimm M, Biegner T, Teriete P, Hoefert S, Krimmel M, Munz A, Reinert S (2016) Estrogen and progesterone hormone receptor expression in oral cavity cancer. Med Oral Patol Oral y Cir Bucal 21(5):e554Google Scholar
- 41.Li R, Wheeler T, Dai H, Frolov A, Thompson T, Ayala G (2004) High level of androgen receptor is associated with aggressive clinicopathologic features and decreased biochemical recurrence-free survival in prostate: cancer patients treated with radical prostatectomy. Am J Surg Pathol 28(7):928–934CrossRefPubMedGoogle Scholar
- 42.Kauffman EC, Robinson BD, Downes MJ, Powell LG, Lee MM, Scherr DS, Gudas LJ, Mongan NP (2011) Role of androgen receptor and associated lysine-demethylase coregulators, LSD1 and JMJD2A, in localized and advanced human bladder cancer. Mol Carcinog 50(12):931–944CrossRefPubMedPubMedCentralGoogle Scholar
- 44.Magri F, Capelli V, Rotondi M, Leporati P, La Manna L, Ruggiero R, Malovini A, Bellazzi R, Villani L, Chiovato L (2012) Expression of estrogen and androgen receptors in differentiated thyroid cancer: an additional criterion to assess the patient’s risk. Endocr Relat Cancer 19(4):463–471CrossRefPubMedGoogle Scholar